Bernstein SocGen Group analyst Lee Hambright lowered the price target on DexCom (NASDAQ: DXCM) to $77.00 (from $83.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE